Domino for Life Sciences
The platform for data-driven drug development
Top life sciences companies trust Domino for data science innovation
Robust analytics and AI solutions for the entire pharma value chain
In a rapidly evolving data landscape, Domino’s future-proof platform empowers life sciences companies to enhance collaboration, streamline workflows, and support the entire pharmaceutical lifecycle, from early research and discovery to clinical analytics and post-launch activities.
Our mission is to bridge the gap between data science, IT, and business teams with a single, unified platform. Power faster time to insights, reduce costs, and accelerate time-to-market for new therapies while maintaining the highest standards for data integrity and compliance.
- Bioinformatics
- Discovery
- Clinical Trials / SCE
- Commercial / Operations
Turn data into insights faster with streamlined bioinformatics workflows
Utilize state-of-the-art data science technologies like machine learning operations (MLOps) and Nextflow to streamline DNA/RNA sequencing and proteomics workflows. Accelerate research on vaccines, cancer prevention, cell mutation predictions, personalized medicine, and drug discovery.
Top 10 global pharmaceutical company
Learn how this customer used Domino MLOps to analyze data from over 10,000 tumors to identify new classes of drugs and the discovery of a specific chromosome that can impact immunity to cancer cells.
Accelerate the discovery process and make informed decisions in drug development
Integrate siloed data sources and apply the use of machine learning (ML) to discover patterns acting as a catalyst for research and accelerating the discovery process. Domino for Life Sciences reduces the time it takes to identify new targets, design proteins, and generate new molecules.
See how Lilly is driving value with ML strategies across their business, including using data science and ML to understand single-cell trajectories for different disease states, powering the discovery of new therapies.
Drive more efficient clinical trials with a cutting-edge Statistical Computing Environment (SCE)
Learn how GSK modernized their clinical trial analytics reporting with the Domino SCE for Life Sciences to drive flexibility, innovation, and efficiency across their end-to-end clinical analyses.
The Domino SCE for Life Sciences is a centrally managed, audit-ready GxP platform with next-level flexibility, scalability, and governance. This environment provides a robust and user-friendly interface for complex biological data, ensuring accuracy, reproducibility, and compliance with the highest regulatory standards.
Increase productivity, reduce costs, and enhance patient experiences
Domino allows Bayer’s sales teams to access more detailed information about customers’ specific needs to deliver personalized product recommendations for each customer. This customized approach improves customer success and satisfaction.
Leverage data science and train ML models to drive value across operations, sales, and marketing. Achieve more accurate demand forecasting and predictive maintenance, or launch personalized omnichannel marketing campaigns and construct unique patient engagement programs.
Unleash your ML and Statistical Computing Environment potential
Domino for Life Sciences is a modern data science platform and Statistical Computing Environment trusted by the world’s leading pharmaceutical companies. The platform combines highly scalable tools and infrastructure with unparalleled collaboration and governance to accelerate both GxP and non-GxP work.
- Run workloads anywhere — on-premises, cloud, or hybrid
- Onboard, upskill, and collaborate with any tool, language, or IDE
- Make data and workflows accessible, reproducible, and reusable
- Rapidly develop, scale, and deploy models up to 90% faster
- Always audit-ready with automatic versioning, tracking, reproducibility, and best-in-class governance
Achieve real value with Domino for Life Sciences
33% more time for research by automating tasks
10x increase in compound discovery
Naveen Singla
Former Data Science Center of Excellence Lead, Bayer
“Domino has made it easier for users across the global enterprise, using different tools and with varied backgrounds and skill sets, to work with each other, leverage past work, and collaborate quickly.”
Eileen Ching
Senior Director, Technical Capability Delivery R&D Biostatistics, GSK
“The reason we chose Domino was because of its flexibility. We wanted a single platform for both exploratory and GxP work.”
Pharma Tech Outlook
“Domino Data Lab: Imbuing innovation in model-driven businesses”
“With the help of Domino’s platform, BMS’s translational bioinformatics team can now successfully test tens of thousands of hypotheses with complete reproducibility to accelerate their fight against cancer.”
